Insulet Price to Book Ratio 2010-2023 | PODD
Historical price to book ratio values for Insulet (PODD) over the last 10 years. The current price to book ratio for Insulet as of April 26, 2024 is 15.84.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Insulet Price/Book Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | Book Value per Share | Price to Book Ratio |
2024-04-26 | 166.19 | 15.86 | |
2023-12-31 | 216.98 | $10.48 | 20.70 |
2023-09-30 | 159.49 | $8.70 | 18.33 |
2023-06-30 | 288.34 | $7.94 | 36.34 |
2023-03-31 | 318.96 | $7.21 | 44.21 |
2022-12-31 | 294.39 | $6.85 | 42.95 |
2022-09-30 | 229.40 | $6.16 | 37.21 |
2022-06-30 | 217.94 | $6.09 | 35.80 |
2022-03-31 | 266.39 | $6.44 | 41.34 |
2021-12-31 | 266.07 | $8.04 | 33.09 |
2021-09-30 | 284.23 | $7.22 | 39.34 |
2021-06-30 | 274.51 | $6.69 | 41.02 |
2021-03-31 | 260.92 | $8.84 | 29.52 |
2020-12-31 | 255.63 | $9.14 | 27.96 |
2020-09-30 | 236.59 | $9.03 | 26.19 |
2020-06-30 | 194.26 | $8.59 | 22.62 |
2020-03-31 | 165.68 | $0.94 | 177.08 |
2019-12-31 | 171.20 | $1.21 | 141.39 |
2019-09-30 | 164.93 | $2.44 | 67.68 |
2019-06-30 | 119.38 | $4.15 | 28.75 |
2019-03-31 | 95.09 | $3.75 | 25.36 |
2018-12-31 | 79.32 | $3.58 | 22.14 |
2018-09-30 | 105.95 | $3.35 | 31.62 |
2018-06-30 | 85.70 | $3.04 | 28.21 |
2018-03-31 | 86.68 | $2.90 | 29.84 |
2017-12-31 | 69.00 | $2.72 | 25.39 |
2017-09-30 | 55.08 | $1.28 | 43.14 |
2017-06-30 | 51.31 | $1.12 | 46.01 |
2017-03-31 | 43.09 | $1.10 | 39.25 |
2016-12-31 | 37.68 | $1.10 | 34.28 |
2016-09-30 | 40.94 | $1.13 | 36.11 |
2016-06-30 | 30.24 | $0.48 | 63.08 |
2016-03-31 | 33.16 | $0.46 | 71.74 |
2015-12-31 | 37.81 | $0.60 | 63.24 |
2015-09-30 | 25.91 | $0.97 | 26.75 |
2015-06-30 | 30.99 | $1.24 | 25.09 |
2015-03-31 | 33.35 | $1.42 | 23.42 |
2014-12-31 | 46.06 | $1.49 | 30.93 |
2014-09-30 | 36.85 | $1.43 | 25.70 |
2014-06-30 | 39.67 | $1.40 | 28.27 |
2014-03-31 | 47.42 | $2.22 | 21.39 |
2013-12-31 | 37.10 | $2.27 | 16.34 |
2013-09-30 | 36.24 | $2.23 | 16.27 |
2013-06-30 | 31.41 | $2.55 | 12.34 |
2013-03-31 | 25.86 | $2.43 | 10.64 |
2012-12-31 | 21.22 | $0.91 | 23.23 |
2012-09-30 | 21.58 | $1.05 | 20.58 |
2012-06-30 | 21.37 | $1.23 | 17.33 |
2012-03-31 | 19.14 | $1.47 | 13.01 |
2011-12-31 | 18.83 | $1.74 | 10.81 |
2011-09-30 | 15.26 | $1.76 | 8.67 |
2011-06-30 | 22.17 | $1.99 | 11.13 |
2011-03-31 | 20.62 | $1.30 | 15.81 |
2010-12-31 | 15.50 | $1.46 | 10.63 |
2010-09-30 | 14.14 | $0.83 | 16.95 |
2010-06-30 | 15.05 | $1.10 | 13.73 |
2009-12-31 | 14.28 | $1.64 | 8.71 |
2009-09-30 | 11.23 | $0.01 | 1145.92 |
2009-06-30 | 7.70 | $-0.12 | -61.90 |
2009-03-31 | 4.10 | $0.56 | 7.38 |
2010-03-31 | 15.09 | $1.08 | 13.99 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $11.637B | $1.697B |
Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $186.584B | 24.49 |
Stryker (SYK) | United States | $127.690B | 31.66 |
Boston Scientific (BSX) | United States | $107.347B | 34.19 |
Medtronic (MDT) | Ireland | $105.881B | 14.99 |
EssilorLuxottica (ESLOY) | France | $98.566B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $43.036B | 0.00 |
Haleon (HLN) | United Kingdom | $38.584B | 30.18 |
ResMed (RMD) | United States | $32.074B | 30.08 |
Terumo (TRUMY) | Japan | $24.746B | 34.95 |
Zimmer Biomet Holdings (ZBH) | United States | $24.522B | 15.79 |
Baxter (BAX) | United States | $20.379B | 14.86 |
Koninklijke Philips (PHG) | Netherlands | $19.567B | 15.61 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.689B | 0.00 |
Demant (WILYY) | Denmark | $9.943B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $7.869B | 23.44 |
BellRing Brands (BRBR) | United States | $7.379B | 39.68 |
Haemonetics (HAE) | United States | $4.621B | 23.63 |
Lantheus Holdings (LNTH) | United States | $4.494B | 11.60 |
Perrigo (PRGO) | Ireland | $4.328B | 12.38 |
GN Store Nord (GNNDY) | Denmark | $4.065B | 26.32 |
Envista Holdings (NVST) | United States | $3.504B | 13.33 |
Prestige Consumer Healthcare (PBH) | United States | $3.499B | 16.54 |
QuidelOrtho (QDEL) | United States | $2.651B | 9.62 |
Neogen (NEOG) | United States | $2.630B | 25.29 |
Green Thumb Industries (GTBIF) | United States | $2.571B | 81.47 |
ICU Medical (ICUI) | United States | $2.311B | 17.24 |
TG Therapeutics (TGTX) | United States | $2.082B | 673.50 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.936B | 0.00 |
Owens & Minor (OMI) | United States | $1.922B | 18.45 |
Agios Pharmaceuticals (AGIO) | United States | $1.770B | 0.00 |
Verano Holdings (VRNOF) | United States | $1.697B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $1.469B | 48.49 |
InMode (INMD) | Israel | $1.439B | 7.45 |
National Vision Holdings (EYE) | United States | $1.400B | 43.61 |
AdaptHealth (AHCO) | United States | $1.324B | 9.96 |
Warby Parker (WRBY) | United States | $1.271B | 0.00 |
AtriCure (ATRC) | United States | $1.121B | 0.00 |
MacroGenics (MGNX) | United States | $0.911B | 0.00 |
Canopy Growth (CGC) | Canada | $0.893B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.794B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.709B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.682B | 14.73 |
Evolus (EOLS) | United States | $0.662B | 0.00 |
Jin Medical (ZJYL) | China | $0.626B | 0.00 |
Quanterix (QTRX) | United States | $0.595B | 0.00 |
Valneva SE (VALN) | France | $0.532B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.516B | 11.17 |
PetIQ (PETQ) | United States | $0.486B | 18.16 |
TerrAscend (TSNDF) | Canada | $0.486B | 0.00 |
ZimVie (ZIMV) | United States | $0.431B | 26.37 |
Biote (BTMD) | United States | $0.411B | 3.91 |
OraSure Technologies (OSUR) | United States | $0.407B | 6.73 |
Surmodics (SRDX) | United States | $0.373B | 40.26 |
Aurora Cannabis (ACB) | Canada | $0.365B | 0.00 |
Zynex (ZYXI) | United States | $0.361B | 41.52 |
Viemed Healthcare (VMD) | United States | $0.322B | 31.96 |
Cerus (CERS) | United States | $0.310B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.279B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.250B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.237B | 14.65 |
Organigram Holdings (OGI) | Canada | $0.192B | 0.00 |
Veru (VERU) | United States | $0.186B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.183B | 0.00 |
Omeros (OMER) | United States | $0.183B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.170B | 0.00 |
High Tide (HITI) | Canada | $0.161B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.156B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.144B | 72.36 |
FitLife Brands (FTLF) | United States | $0.132B | 21.28 |
Jushi Holdings (JUSHF) | United States | $0.131B | 0.00 |
InterCure (INCR) | Israel | $0.121B | 20.46 |
Fonar (FONR) | United States | $0.103B | 8.84 |
MariMed (MRMD) | United States | $0.100B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.100B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.098B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.092B | 0.00 |
Safety Shot (SHOT) | United States | $0.082B | 0.00 |
Chimerix (CMRX) | United States | $0.080B | 0.00 |
Brainsway (BWAY) | Israel | $0.079B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.058B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.054B | 3.53 |
Apyx Medical (APYX) | United States | $0.050B | 0.00 |
Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
ImmuCell (ICCC) | United States | $0.040B | 0.00 |
United-Guardian (UG) | United States | $0.038B | 14.77 |
Bright Green (BGXX) | United States | $0.038B | 0.00 |
Modular Medical (MODD) | United States | $0.035B | 0.00 |
Exagen (XGN) | United States | $0.024B | 0.00 |
Nephros (NEPH) | United States | $0.023B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.019B | 0.00 |
Flora Growth (FLGC) | United States | $0.017B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
Agape ATP (ATPC) | $0.017B | 0.00 | |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
GlucoTrack (GCTK) | United States | $0.012B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.010B | 71.82 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Sharps Technology (STSS) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |